CD274 and glioma: As mentioned above, lipid nanoparticles containing PD-L1 antibody not only have targeted functions but also inhibit PD-L1 and enhance T cell anti-tumor immunity and kill glioma cells in synergism with radiotherapy (48) (Figure 4).